MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Increased anti-MAG autoantibodies titers in Parkinson’s disease

    E. Papuc, K. Rejdak (Lublin, Poland)

    Objective: To search for biomarkers of neurodegenerative process in Parkinson's disease (PD).There is emerging evidence that humoral response may be involved in the pathogenesis and…
  • 2016 International Congress

    Hyperin inhibits lipopolysaccharide-induced microglia activation through p38 and NFκB signaling

    X. Zhang, Y.N. Wang, H.H. Fan, R. Yang, S.Y. Li, J.H. Zhu (Wenzhou, People's Republic of China)

    Objective: In this study, we aimed to investigate hyperin's potentiality in inhibition of neuroinflammation. Background: Hyperin is an active compound isolated from Rhododendron brachycarpum G.…
  • 2016 International Congress

    Constipation in early de novo Parkinson’s disease: Prevalence and correlates with clinical features, imaging and non-imaging biomarkers

    G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To explore the association between constipation and clinical features, imaging and non-imaging biomarkers in early de novo (untreated) Parkinson's disease (PD) patients. Background: Constipation…
  • 2016 International Congress

    Diffusion tensor imaging biomarkers of nigrostriatal neurodegeneration in early Parkinson’s disease

    J.A. Pineda-Pardo, G. Foffani, J.A. Obeso (Madrid, Spain)

    Objective: Identify magnetic resonance imaging (MRI) biomarkers of nigrostriatal neurodegeneration in early-stage drug-naïve Parkinson's disease (PD). Background: Diffusion tensor imaging (DTI) is an MRI technique…
  • 2016 International Congress

    Is levodopa-induced dyskinesia in Parkinson’s disease associated with increased blood brain barrier permeability and volumetric changes?

    O. Segal, D. Last, D. Guez, Y. Mardor, G. Yahalom, O.S. Cohen, S. Benizri, C. Hoffman, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: The aim of this study was to explore the angiogenetic hypothesis for Levodopa-induced-dyskinesia (LID) using advanced MRI methods in patients with Parkinson's disease (PD).…
  • 2016 International Congress

    1 to 40 years later: Delayed effects of brain radiation presenting as parkinsonism

    R. Mehanna, J. Jimenez-Shahed, I. Itin, R. Mehanna (Houston, TX, USA)

    Objective: To report 3 adult cases of delayed radiation induced parkinsonism, with latency ranging from 1 to 40 years. . Background: Unequivocal radiation induced parkinsonism…
  • 2016 International Congress

    Fragile X-associated tremor/ataxia syndrome in two female patients

    L. Hvizdosova, M. Kaiserova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To report two cases of female patients with FXTAS. Background: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder with core features of action…
  • 2016 International Congress

    Transcranial sonography of the substantia nigra and its correlation with iron metabolism and c-reactive protein in Parkinson’s disease

    X. Yang, J. Liu, Y. Qian, S. Xu, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To measure the echogenicity of the substantia nigra (SN) by transcranial sonography (TCS) in PD patients and discuss its correlation with iron metabolism and…
  • 2016 International Congress

    Real world conversion of levodopa to a novel extended release levodopa preparation: Determining predictors and dose ratios

    W. Ondo, P. Coss, M. Christie (Houston, TX, USA)

    Objective: To determine predictors of response and conversion ratios for a novel extended release levodopa preparation. Background: A new extended release levodopa preparation, Rytary®, has…
  • 2016 International Congress

    Disrupted hubs in functional brain networks in subtype-specific Parkinson’s disease

    L. Ma, H. Chen, T. Feng (Beijing, People's Republic of China)

    Objective: To detect the changing pattern in functional network hubs in subtype-specific Parkinson's disease (PD) using resting-state functional magnetic resosonce imaging (Rs-fMRI). Background: PD is…
  • « Previous Page
  • 1
  • …
  • 384
  • 385
  • 386
  • 387
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley